Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Stroke patients taken directly to treatment may recover better

NCT ID NCT03969511

Disease control Sponsor: Central Hospital, Nancy, France Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether taking people with severe stroke symptoms directly to the angio-suite for clot removal, instead of first doing a CT or MRI scan, leads to better recovery at 3 months. About 120 adults aged 18-85 with severe stroke were randomly assigned to either direct angio-suite admission or standard care. The goal was to see if faster treatment improves independence in daily activities.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could show that faster treatment by skipping initial scans improves independence after severe stroke.
What could go wrong
The trial was terminated early with only 120 participants, so results may be inconclusive. Direct transfer might not benefit all patients and could miss other treatable conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

120 people

The number who actually took part.

Started

Jul 2020

Finished

Apr 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged from 18 to 85 years, * Rapid neurological examination by the neurologist of the participating centre before randomization, * Suffered from acute severe neurological deficit at hospital admission confirmed by neurologist defined as: * Unilateral motor deficit with a total score ≥ 5 1. Facial palsy: item 4 of NIHSS (score 0 to 2) 2. Arm: item 5 of NIHSS (score 0 to 4) 3. Leg: item 6 of NIHSS (score 0 to 2) AND * Cortical symptom with a total score ≥ 1 1. Language: item 9 of NIHSS (score 0 to 3) 2. Extinction: item 11 of NIHSS (score 0 to 2) * Patients who admitted to hospital within 5 hours after symptom onset * Known onset time of symptom * Only mothership admissions * Fully autonomous patient (pre-stroke mRS ≤2) * Availability of the angio-suite and endovascular treatment team at the randomization * Person affiliated to or beneficiary of a social security plan Exclusion Criteria: * Severe allergy to iodinated contrast agents, * Ongoing pregnancy, * Breastfeeding, * Consent refusal or opposition of the relatives, * Individuals under mandatory legal guardianship or unable to consent and whose relatives oppose the research, * Any conditions that could hamper the 3-month outcome recording

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute ischemic stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

ischemic stroke large artery stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute ischemic stroke

Contacts and locations

Locations

  • Centre Hospitalier Régional Universitaire

    Nancy, 54035, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.